These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


424 related items for PubMed ID: 11230735

  • 1. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
    Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S.
    Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
    [Abstract] [Full Text] [Related]

  • 2. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN.
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.
    Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S.
    Proc Natl Acad Sci U S A; 2002 Jul 23; 99(15):10060-5. PubMed ID: 12110732
    [Abstract] [Full Text] [Related]

  • 4. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
    Park HJ, Yu E, Shim YH.
    Cancer Lett; 2006 Feb 28; 233(2):271-8. PubMed ID: 15885882
    [Abstract] [Full Text] [Related]

  • 5. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S.
    Hepatology; 2000 Nov 28; 32(5):970-9. PubMed ID: 11050047
    [Abstract] [Full Text] [Related]

  • 6. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
    Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H, Hirohashi S.
    Hepatology; 1999 Mar 28; 29(3):703-9. PubMed ID: 10051471
    [Abstract] [Full Text] [Related]

  • 7. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 8. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May 18; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 9. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers.
    Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S.
    Am J Pathol; 2004 Feb 18; 164(2):689-99. PubMed ID: 14742272
    [Abstract] [Full Text] [Related]

  • 10. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
    Esfandiari F, Green R, Cotterman RF, Pogribny IP, James SJ, Miller JW.
    Carcinogenesis; 2003 Dec 18; 24(12):1935-40. PubMed ID: 12949043
    [Abstract] [Full Text] [Related]

  • 11. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
    Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S.
    J Urol; 2005 May 18; 173(5):1767-71. PubMed ID: 15821584
    [Abstract] [Full Text] [Related]

  • 12. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 13. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 02; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 14. Expression of DNA methyltransferases in multistep hepatocarcinogenesis.
    Choi MS, Shim YH, Hwa JY, Lee SK, Ro JY, Kim JS, Yu E.
    Hum Pathol; 2003 Jan 02; 34(1):11-7. PubMed ID: 12605361
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 17. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
    Hassan KM, Norwood T, Gimelli G, Gartler SM, Hansen RS.
    Hum Genet; 2001 Oct 01; 109(4):452-62. PubMed ID: 11702227
    [Abstract] [Full Text] [Related]

  • 18. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.
    Hepatology; 2012 Nov 01; 56(5):1817-27. PubMed ID: 22689435
    [Abstract] [Full Text] [Related]

  • 19. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH.
    Clin Cancer Res; 2009 Feb 01; 15(3):812-20. PubMed ID: 19188151
    [Abstract] [Full Text] [Related]

  • 20. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state.
    Kanai Y, Hirohashi S.
    Carcinogenesis; 2007 Dec 01; 28(12):2434-42. PubMed ID: 17893234
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.